Company profile
Hemab Therapeutics Holdings, Inc. Insider Trading
COAGEvery SEC Form 4 insider trading filing for Hemab Therapeutics Holdings, Inc. (COAG) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0002114044
- Filings
- 9
- Insiders
- 10
- Last filing
- 2026-06-16
Activity summary
No insider transactions in the last 30 days. The most recent was on June 16, 2026, when RA CAPITAL MANAGEMENT, L.P. bought 61,523 shares. 9 filings from 10 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q1 26 to Q2 26. Hemab Therapeutics Holdings, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $55.5M.
No insider activity recorded for COAG in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. | COAG | Purchase | 61,523 | $24.98 | $1.54M |
| Jun 15, 2026 | RA CAPITAL MANAGEMENT, L.P. | COAG | Purchase | 6,146 | $24.89 | $153K |
| May 20, 2026 | RA CAPITAL MANAGEMENT, L.P. | COAG | Purchase | 996 | $24.94 | $25K |
| May 19, 2026 | RA CAPITAL MANAGEMENT, L.P. | COAG | Purchase | 3,802 | $24.97 | $95K |
| May 12, 2026 | RA CAPITAL MANAGEMENT, L.P. | COAG | Purchase | 6,387 | $24.90 | $159K |
34 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=COAG" \
-H "X-Api-Key: $KEY"